AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes
Keywords: HbA1c، هموگلوبین A1c; DPP4, dipeptidyl peptidase inhibitor 4; GLP-1, glucagon-like peptide-1; GPR119, G-protein-coupled receptor 119; GSIS, glucose-stimulated insulin secretion; HbA1c, hemoglobin A1c; HEK, human embryonic kidney; LPC, lysophosphatidylcholine; OEA, oleoylethano